SCHEMBL5489472

SCHEMBL5489472

Nc1ccc2ncc(N)n2n1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 1/20 0.42
ADORA3 P0DMS8 1/20 0.42
ADORA2A P29274 1/20 0.42
ADORA2B P29275 1/20 0.42
ADORA1 P30542 1/20 0.42
CREBBP Q92793 1/20 0.42
FYN P06241 8/20 0.37
TNF P01375 1/20 0.36
DYRK3 O43781 5/20 0.35
DYRK1A Q13627 5/20 0.35
DYRK2 Q92630 5/20 0.35
DYRK1B Q9Y463 5/20 0.35
CCNA2 P20248 4/20 0.35
CDK2 P24941 4/20 0.35
CDK5 Q00535 4/20 0.35
CDK5R1 Q15078 4/20 0.35
CCNT1 O60563 3/20 0.35
CDK9 P50750 3/20 0.35
IKBKB O14920 1/20 0.34
MET P08581 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12503772 0.79 BRD4 (0.40) BRD4ADORA3ADORA2AADORA2BADORA1
SCHEMBL15258012 0.79 BRD4 (0.43) BRD4ADORA3ADORA2AADORA2BADORA1
SCHEMBL10246682 0.79 TNF (0.57) TNFDYRK3DYRK1ADYRK2DYRK1B
SCHEMBL31691002 0.75 TGFBR1 (0.45)
SCHEMBL1202203 0.74 FYN (0.59) FYNDYRK1AKDM4ENPC1RAB9A
SCHEMBL3037756 0.72 FYN (0.61) FYN
SCHEMBL1055021 0.71 FYN (0.62) FYNDYRK1ADYRK2
SCHEMBL3359311 0.70 FYN (0.47) FYNDYRK3DYRK1ADYRK2DYRK1B
SCHEMBL2392859 0.68 MKNK1 (0.53) FYNDYRK3DYRK1ADYRK2DYRK1B
Ammonia Solution, Strong SCHEMBL3040252 0.67 KMT2A (0.35) FYNMETKDM4ENPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7306631-B2 Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof THE PROCTER & GAMBLE COMPANY (US) 2007-12-11 US disclosed
EP-1732509-A1 KERATIN DYEING COMPOSITIONS BICYCLIC 5-6 HETEROAROMATIC DYEING COMPOUNDS WITH ONE RING NITROGEN JUNCTION The Procter and Gamble Company (US) 2006-12-20 EP disclosed
WO-2005097052-A1 KERATIN DYEING COMPOSITIONS BICYCLIC 5-6 HETEROAROMATIC DYEING COMPOUNDS WITH ONE RING NITROGEN JUNCTION THE PROCTER & GAMBLE COMPANY (US) 2005-10-20 WO disclosed
US-20050229333-A1 Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof PROCTER & GAMBLE COMPANY, THE 2005-10-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050229333-A1 Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof KRT18, CKMT1A; CKMT1B, JUP BRD4 1344/4885ADORA3 4765/4885ADORA2A 4827/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.